u 73122 has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, MS; Kim, SH; Yang, SH | 1 |
| Joseph, AM; Kamath, A; Mittal, S; Rajala, MS | 1 |
| Di Florio, A; Jensen, RT; Moody, TW | 1 |
3 other study(ies) available for u 73122 and Lung Neoplasms
| Article | Year |
|---|---|
Restricting extracellular Ca2+ on gefitinib-resistant non-small cell lung cancer cells reverses altered epidermal growth factor-mediated Ca2+ response, which consequently enhances gefitinib sensitivity.
Topics: Antineoplastic Agents; Calcium Signaling; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Estrenes; Gefitinib; Humans; Lung Neoplasms; NFATC Transcription Factors; Pyrrolidinones; Type C Phospholipases | 2020 |
PLCγ1‑dependent invasion and migration of cells expressing NSCLC‑associated EGFR mutants.
Topics: Afatinib; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Movement; Cell Proliferation; ErbB Receptors; Estrenes; Gefitinib; Humans; Lung Neoplasms; Mutation; Neoplasm Invasiveness; Phosphodiesterase Inhibitors; Phospholipase C gamma; Protein Kinase Inhibitors; Pyrrolidinones; Recombinant Proteins; Signal Transduction | 2020 |
PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells.
Topics: Calcium Signaling; Cell Line, Tumor; Chelating Agents; Cytosol; Egtazic Acid; Estrenes; Focal Adhesion Kinase 2; Humans; Isoquinolines; Lung Neoplasms; Neoplasm Proteins; Peptide Fragments; Phosphodiesterase Inhibitors; Phosphorylation; Phosphotyrosine; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrrolidinones; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Sulfonamides | 2012 |